par Van Laethem, Jean-Luc 
Référence Bulletin du cancer, 95, 3, page (369-373)
Publication Publié, 2008-03
Référence Bulletin du cancer, 95, 3, page (369-373)
Publication Publié, 2008-03
Article révisé par les pairs
| Titre: |
|
| Auteur: | Van Laethem, Jean-Luc |
| Informations sur la publication: | Bulletin du cancer, 95, 3, page (369-373) |
| Statut de publication: | Publié, 2008-03 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | EGFR |
| Gemcitabine | |
| Meta-analysis | |
| Pancreatic cancer | |
| MeSH keywords: | Antibodies, Monoclonal |
| Antimetabolites, Antineoplastic -- therapeutic use | |
| Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
| Cisplatin -- administration & dosage | |
| Clinical Trials, Phase III as Topic | |
| Deoxycytidine -- administration & dosage -- analogs & derivatives | |
| Humans | |
| Meta-Analysis as Topic | |
| Organoplatinum Compounds -- administration & dosage | |
| Pancreatic Neoplasms -- drug therapy -- surgery | |
| Quinazolines -- administration & dosage | |
| Note générale: | English Abstract |
| Journal Article | |
| Review | |
| Langue: | Français |
| Identificateurs: | urn:issn:0007-4551 |
| info:doi/10.1684/bdc.2008.0601 | |
| info:pii/bdc.2008.0601 | |
| info:scp/42149142323 | |
| info:pmid/18390419 |
